MyFinsight
Home
About
Contact
alny: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, ALNY has $4,851,662K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
4,851,662
4,566,019
Total stockholders' equity
233,894
250,591
Total liabilities and stockholders' equity
4,851,662
4,566,019
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$188,036K
Inventory
$75,383K
Accounts receivable, net
$964,768K
Marketable debt securities
$1,234,375K
Cash and cash
equivalents
$1,490,249K
Other assets
$55,835K
Restricted investments
$51,314K
Deferred tax assets
$98,558K
Operating lease
right-of-use assets
$191,390K
Property, plant and
equipment, net
$501,754K
Total current assets
$3,952,811K
Total assets
$4,851,662K
Total liabilities and
stockholders' equity
$4,851,662K
Total stockholders'
equity
$233,894K
Total liabilities
$4,617,768K
Accumulated deficit
-$7,160,420K
Accumulated other
comprehensive loss
-$21,775K
Additional paid-in capital
$7,414,771K
Other liabilities
$9,769K
Development derivative
liability, net of current...
$439,659K
Liability related to the
sale of future...
$1,349,166K
Convertible debt
$1,040,276K
Operating lease
liabilities, net of current...
$223,421K
Total current
liabilities
$1,555,477K
Common stock, 0.01 par
value per share,...
$1,318K
Development derivative
liability
$121,251K
Liability related to the
sale of future...
$115,691K
Deferred revenue
$2,541K
Operating lease
liabilities
$44,755K
Accrued expenses
$1,153,648K
Accounts payable
$117,591K
Buy me a coffee
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)